Implementing Tobacco Treatment in Low Dose CT Lung Cancer Screening Sites
Public ClinicalTrials.gov record NCT03315910. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study is to help determine the most effective type or combination of treatments to offer patients seeking lung cancer screening who are smokers to help them reduce the number of cigarettes they smoke, or quit smoking. The investigators long term goal is to increase the benefits of lung cancer screening by providing a blue print of best practices for screening sites to deliver tobacco treatment to their patients who are smokers, in a way that does not add burden to screening site staff and increases the chances of patients quitting smoking.
Study identification
- NCT ID
- NCT03315910
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Phase 4
- Enrollment
- 807 participants
Conditions and interventions
Conditions
Interventions
- Motivational Interviewing (MI) Behavioral
- Nicotine Replacement Therapy (NRT) Drug
- Nicotine Lozenge Drug
- Message Framing Behavioral
- saliva sample Other
Behavioral · Drug · Other
Eligibility (public fields only)
- Age range
- 50 Years to 80 Years
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 9, 2017
- Primary completion
- Sep 30, 2026
- Completion
- Sep 30, 2026
- Last update posted
- Nov 23, 2025
2017 – 2026
United States locations
- U.S. sites
- 18
- U.S. states
- 12
- U.S. cities
- 17
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Southern California (Data Collection Only) | Los Angeles | California | 90033 | — |
| John Muir Health | Walnut Creek | California | 94598 | — |
| WellStar Health System | La Grange | Georgia | 30240 | — |
| Rush University Medical Center | Chicago | Illinois | 606012 | — |
| Riverside Healthcare | Kankakee | Illinois | 60901 | — |
| St. Mary Medical Center, Community Healthcare System | Crown Point | Indiana | 46307 | — |
| MercyOne Des Moines Medical Center (Data Collection Only) | Des Moines | Iowa | 50314 | — |
| Maine Medical Center Cancer Institute | Scarborough | Maine | 04074 | — |
| Henry Ford Hospital (Data collection only) | Detroit | Michigan | 48202 | — |
| Munson Healthcare | Traverse City | Michigan | 49684 | — |
| NYU Winthrop Hospital | Mineola | New York | 11501 | — |
| Memorial Sloan Kettering Cancer Center | New York | New York | 10065 | — |
| Weill Cornell Medical Center | New York | New York | 10065 | — |
| Montefiore Medical Center (Data Collection Only) | The Bronx | New York | 10467 | — |
| Carolinas Healthcare System Blue Ridge | Morganton | North Carolina | 28655 | — |
| Fairfield Medical Center | Lancaster | Ohio | 43130 | — |
| Legacy Health | Portland | Oregon | 97210 | — |
| Temple University | Philadelphia | Pennsylvania | 19140 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03315910, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 23, 2025 · Synced Sep 5, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03315910 live on ClinicalTrials.gov.